Mackay Shields LLC’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,700
Closed -$251K 1405
2021
Q1
$251K Sell
16,700
-2,800
-14% -$44.8K ﹤0.01% 1367
2020
Q4
$281K Buy
+19,500
New +$236K ﹤0.01% 1362

Other funds holding MDRX

Mackay Shields LLC's MDRX Position: Q2 2021 in Review

Mackay Shields LLC sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2021, closing a stake of 16,700 shares — an estimated $251K sold.

Mackay Shields LLC first reported a position in MDRX in Q4 2020 and held it in 2 quarters. The position peaked at $281K in Q4 2020. 235 funds tracked by Wall St. Rank hold MDRX as of Q2 2021.

  • Mackay Shields LLC reported no remaining Veradigm Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 16,700 Veradigm Inc. Common Stock shares in Q2 2021, an estimated $251K.
  • Mackay Shields LLC first reported a position in Veradigm Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Mackay Shields LLC's Veradigm Inc. Common Stock position peaked at $281K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.